August Bioservices has filed a notice of an exempt offering of securities to raise $65,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, August Bioservices is raising $65,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jenn Adams played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About August Bioservices
August Bioservices is a Contract Development and Manufacturing Organization (CDMO) headquartered in Nashville, Tennessee. August Bio offers a full range of pharmaceutical contract development and manufacturing services to pharmaceutical and biotech clients. We focus on sterile injectables, topicals, highly-complex formulations, poorly soluble & highly viscous compounds, Uncommon container sizes & fill volumes and offer aseptic and non-aseptic terminally sterilized filling of vials (liquid and lyophilized), syringes and flexible IV bags.
To learn more about August Bioservices, visit https://www.augustbio.com/
Contact:
Jenn Adams, Chief Executive Officer
615-515-5400
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved